G6PD and neoplasm: Glucose-6-phosphate dehydrogenase (G6PD) is verified to be an independent risk factor related to the adverse outcomes of HCC, and exacerbates tumor growth, invasion, and metastasis, along with reduced ferroptosis through suppressing cytochrome P450 oxidoreductase (POR) (Cao et al., 2021).